Differences in the duration of diuretic effects and impact on the renin-angiotensin-aldosterone system of furosemide in healthy dogs

Journal of Veterinary Medical Science

Volumn 72, Issue 1, 2010, Pages 13-18

  Hori, Yasutomo ^a   Ohshima, Naoko ^a   Kanai, Kazutaka ^a   Hoshi, Fumio ^a   Itoh, Naoyuki ^a   Higuchi, Sei Ichi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Canine; Diuretic resistance; Loop diuretics; Plasma aldosterone concentrations

Indexed keywords

DIURETIC AGENT; FUROSEMIDE;

ANIMAL; ARTICLE; CLINICAL TRIAL; DOG; DRUG EFFECT; FEMALE; MALE; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; DIURETICS; DOGS; FEMALE; FUROSEMIDE; MALE; RENIN-ANGIOTENSIN SYSTEM;

CANIS FAMILIARIS;

EID: 76449106213     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.09-0259     Document Type: Article

References (37)

1. Adin, D.B., Taylor, A.W., Hill, R.C., Scott, K.C. and Martin, F.G. 2003. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. J. Vet. Intern. Med. 17: 632-636.
2. Aramaki, Y., Uechi, M. and Takase, K. 2003. Angiotensin converting enzyme and chymase activity in the feline heart and serum. J. Vet. Med. Sci. 65: 1115-1118.
3. Brater, D.C. 1996. Benefits and risks of torasemide in congestive heart failure and essential hypertension. Drug Saf. 14: 104-120.
4. Brater, D.C. 1979. Renal sites of action of azosemide. Clin. Pharmacol. Ther. 25: 428-434.
5. Brater, D.C., Day, B., Anderson, S. and Seiwell, R. 1983. Azosemide kinetics and dynamics. Clin. Pharmacol. Ther. 34: 454-458.
6. Cataliotti, A., Boerrigter, G., Costello-Boerrigter, L.C., Schirger, J.A., Tsuruda, T., Heublein, D.M., Chen, H.H., Malatino, L.S. and Burnett, J.C., Jr. 2004. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation 109: 1680-1685.
7. Cosin, J. and Diez, J. 2002. Torasemide in chronic heart failure: results of the TORIC study. Eur. J. Heart Fail. 4: 507-513.
8. Delarge, J. 1988. Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide. Arzneimittelforschung 38: 144-150.
9. Dormans, T.P., van Meyel, J.J., Gerlag, P.G., Tan, Y., Russel, F.G. and Smits, P. 1996. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J. Am. Coll. Cardiol. 28: 376-382.
10. Ellison, D.H. 1999. Diuretic resistance: physiology and therapeutics. Semin. Nephrol. 19: 581-597.
11. Ellison, D.H. 2001. Diuretic therapy and resistance in congestive heart failure. Cardiology 96: 132-143.
12. Flamenbaum, W. and Friedman, R. 1982. Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new "loop" diuretic. Pharmacotherapy 2: 213-222.
13. Fowler, S.F. and Murray, K.M. 1995. Torsemide: a new loop diuretic. Am. J. Health Syst. Pharm. 52: 1771-1780.
14. Francis, G.S., Siegel, R.M., Goldsmith, S.R., Olivari, M.T., Levine, T.B. and Cohn, J.N. 1985. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann. Intern. Med. 103: 1-6.
15. Hammarlund, M. and Paalzow, L.K. 1985. Acute tolerance development to the diuretic effect of furosemide in the rat. Biopharm. Drug Dispos. 6: 9-21.
16. Hori, Y., Katou, A., Tsubaki, M., Kanai, K., Nakao, R., Hoshi, F., Itoh, N. and Higuchi, S. 2008.Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs. Am. J. Vet. Res. 69: 1664-1669.
17. Hori, Y., Takusagawa, F., Ikadai, H., Uechi, M., Hoshi, F. and Higuchi, S. 2007. Effects of oral administration of furosemide and torsemide in healthy dogs. Am. J. Vet. Res. 68: 1058-1063.
18. Howard, P.A. and Dunn, M.I. 2006. Effectiveness of continuous infusions of loop diuretics for severe heart failure. J. Cardiovasc. Med. (Hagerstown) 7: 5-10.
19. Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T.G., Jessup, M., Konstam, M.A., Mancini, D.M., Michl, K., Oates, J.A., Rahko, P.S., Silver, M.A., Stevenson, L.W., Yancy, C.W., Antman, E.M., Smith, S.C., Jr., Adams, C.D., Anderson, J.L., Faxon, D.P., Fuster, V., Halperin, J.L., Hiratzka, L.F., Jacobs, A.K., Nishimura, R., Ornato, J.P., Page, R.L. and Riegel, B. 2005. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the american college of cardiology/american heart association task force on practice guide-lines (Writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American college of chest physicians and the international society for heart and lung transplantation: endorsed by the heart rhythm society. Circulation 112: e154-235.
20. Kuzuya, F. 1983.Phase 1 study of azosemide (SK-110): single-and multiple-dose study. Int. J. Clin. Pharmacol. Ther. Toxicol. 21: 10-23.
21. Lammintausta, R., Anttila, M. and Viinamaki, O. 1980. Response of renin, aldosterone and antidiuretic hormone to furosemide and furosemide-triamterene combination. Int. J. Clin. Pharmacol. Ther. Toxicol. 18: 395-398.
22. Lee, M.G., Li, T. and Chiou, W.L. 1986. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide. Biopharm. Drug Dispos. semide injection. Endocrinol, Jpn. 33: 497-503.
23. Lopez, B., Querejeta, R., Gonzalez, A., Sanchez, E., Larman, M. and Diez, J. 2004. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J. Am. Coll. Cardiol. 43: 2028-2035.
24. McCurley, J.M., Hanlon, S.U., Wei, S.K., Wedam, E.F., Michalski, M. and Haigney, M.C. 2004. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J. Am. Coll. Cardiol. 44: 1301-1307.
25. Noda, Y., Fukiyama, K., Kumamoto, K., Takishita, S., Eto, T., Kawasaki, T. and Omae, T. 1982. Renin response to furosemide differs with the routes of administration in health men. Jpn. Circ. J. 46: 552-558.
26. Osajima, A., Anai, H., Segawa, K., Muta, T., Takasugi, M. and Kuroiwa, A. 1992. Comparative effects of loop diuretics on AVP-receptor binding and AVP-sensitive adenylate cyclase activity. Nippon Jinzo Gakkai Shi 34: 965-972.
27. Patel, A. and Smith, F.G. 1997. Dose-dependent cardiovascular, renal, and endocrine effects of furosemide in conscious lambs. Can. J. Physiol. Pharmacol. 75: 1101-1107.
28. Paterna, S., Di Pasquale, P., Parrinello, G., Amato, P., Cardinale, A., Follone, G., Giubilato, A. and Licata, G. 2000. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur. J. Heart Fail. 2: 305-313.
29. Suh, O.K., Kim, S.H. and Lee, M.G. 2003. Pharmacokinetics and pharmacodynamics of azosemide. Biopharm. Drug Dispos. 24: 275-297.
30. Suzuki, H., Saruta, T. and Ferrario, C.M. 1986. Changes in central and peripheral renin-angiotensin system after furosemide injection. Endocrinol, Jpn. 33: 497-503.
31. Takai, S., Sakonjo, H., Fukuda, K., Jin, D., Sakaguchi, M., Kamoshita, K., Ishida, K., Sukenaga, Y. and Miyazaki, M. 2003. A novel chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[,4-dioxo -1-phenyl-7-(2-pyridyloxy)]2-heptyl]acetamide (NK3201), suppressed intimal hyperplasia after balloon injury. J. Pharmacol. Exp. Ther. 304: 841-844.
32. Tsutsui, T., Tsutamoto, T., Maeda, K. and Kinoshita, M. 2001. Comparison of neurohumoral effects of short-acting and longacting loop diuretics in patients with chronic congestive heart failure. J. Cardiovasc. Pharmacol. 38 (Suppl.1): S81-85.
33. Uchida, T., Ohtaki, Y., Kido, H. and Watanabe, M. 1991. Diuretic profile of a novel loop diuretic torasemide in rats and dogs. Drugs Exp. Clin. Res. 17: 293-298.
34. Uchida, T., Yamanaga, K., Nishikawa, M., Ohtaki, Y., Kido, H. and Watanabe, M. 1991. Anti-aldosteronergic effect of torasemide. Eur. J. Pharmacol. 205: 145-150.
35. Ueno, Y., Arita, M., Suruda, H., Mohara, O. and Masuyama, Y. 1983. Contributions of central sympathetic neural activity to furosemide-induced increases in plasma renin activity and noradrenaline. Jpn. Heart J. 24: 259-267.
36. van Meyel, J.J., Smits, P., Russel, F.G., Gerlag, P.G., Tan, Y. and Gribnau, F.W. 1992. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin. Pharmacol. Ther. 51: 440-444.
37. Yoshida, J., Yamamoto, K., Mano, T., Sakata, Y., Nishio, M., Ohtani, T, Hori, M., Miwa, T. and Masuyama, T. 2005. Different effects of longand short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. Cardiovasc. Res. 68: 118-127.